Cargando…

Tumor size, but not consolidation‐to‐tumor ratio, is an independent prognostic factor for part‐solid clinical T1 non‐small cell lung cancer

BACKGROUND: Tumor size and consolidation‐to‐tumor ratio (CTR) are crucial for non–small cell lung cancer (NSCLC) prognosis. However, the optimal CTR cutoff remains unclear. Whether tumor size and CTR are independent prognostic factors for part‐solid NSCLC is under debate. Here, we aimed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhihua, Xu, Wenzheng, Gu, Tianhao, Cao, Xincen, Wu, Weibing, Chen, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968594/ https://www.ncbi.nlm.nih.gov/pubmed/36578128 http://dx.doi.org/10.1111/1759-7714.14788

Ejemplares similares

Segmentectomy versus lobectomy for small‐sized pure solid non–small cell lung cancer
por: Li, Zhihua, et al.
Publicado: (2023)

Relationship between consolidation tumor ratio and tumor‐infiltrating lymphocytes in small‐sized lung adenocarcinoma
por: Ono, Yuki, et al.
Publicado: (2022)

Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis
por: Wu, Yongming, et al.
Publicado: (2023)

Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size
por: Koike, Sachie, et al.
Publicado: (2022)

Prognostic Impact of Radiological Consolidation Tumor Ratio in Clinical Stage IA Pulmonary Ground Glass Opacities
por: Xi, Junjie, et al.
Publicado: (2021)

Eighth edition T category is prognostic: the size of the solid component matters, not the ratio
por: Hamanaka, Kazutoshi, et al.
Publicado: (2020)

A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung Adenocarcinoma
por: Zhang, Longfu, et al.
Publicado: (2023)

Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor
por: Cho, Jun Yeun, et al.
Publicado: (2018)

Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma
por: Li, Zhihua, et al.
Publicado: (2022)

Prognostic value of the postoperative neutrophil-lymphocyte ratio in solid tumors: A meta-analysis
por: Wu, Meilong, et al.
Publicado: (2021)

Prognostic Value of Ezrin in Solid Tumors: A Meta-Analysis of the Literature
por: Han, Kun, et al.
Publicado: (2013)

Effect of tumor shape and size on drug delivery to solid tumors
por: Soltani, M, et al.
Publicado: (2012)

Reappraising the clinical usability of consolidation-to-tumor ratio on CT in clinical stage IA lung cancer
por: Yoon, Dong Woog, et al.
Publicado: (2022)

TACC3 as an independent prognostic marker for solid tumors: a systematic review and meta-analysis
por: Wang, June, et al.
Publicado: (2017)

Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
por: Zheng, Qingyuan, et al.
Publicado: (2023)

Thrombocytopenia in solid tumors: Prognostic significance
por: Ghanavat, Majid, et al.
Publicado: (2019)

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors
por: Capuozzo, Maurizio, et al.
Publicado: (2023)

Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25
por: Qi, Yi‐Fan, et al.
Publicado: (2022)

Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis
por: Teng, Jun-Jie, et al.
Publicado: (2015)

Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis
por: He, Jiaxi, et al.
Publicado: (2017)

Expression of Concern: Prognostic value of the postoperative neutrophil-lymphocyte ratio in solid tumors: A meta-analysis
Publicado: (2023)

Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner
por: Papageorgis, Panagiotis, et al.
Publicado: (2017)

Therapeutic Effects of Cold Atmospheric Plasma on Solid Tumor
por: Min, Tianhao, et al.
Publicado: (2022)

Prognostic significance of HER3 in patients with malignant solid tumors
por: Li, Qin, et al.
Publicado: (2017)

Tumor size is an independent negative prognostic factor for event free survival in children with differentiated thyroid cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2022)

Durvalumab as Consolidation Therapy in Post-Multimodal Interventional Treatment for Patients with Advanced Solid Tumors: A Preliminary Study
por: Li, Yuanming, et al.
Publicado: (2022)

Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25
por: Isaka, Tetsuya, et al.
Publicado: (2023)

Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: A PRISMA-compliant meta-analysis
por: Long, Yuming, et al.
Publicado: (2021)

Longitudinal Tumor Size and Neutrophil‐to‐Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Durvalumab
por: Gavrilov, Sergey, et al.
Publicado: (2020)

Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
por: Sarin, Hemant, et al.
Publicado: (2009)

Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors
por: Sefidgar, Mostafa, et al.
Publicado: (2014)

Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization
por: Yang, Xi-Yuan, et al.
Publicado: (2021)

NEIM-13 THE PROGNOSTIC ROLE OF VENTRICULAR SIZE AND ITS DYNAMICS IN PATIENTS WITH LEPTOMENINGEAL METASTASIS FROM SOLID TUMORS
por: Le Rhun, Emilie, et al.
Publicado: (2023)

The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma
por: Aboelnasr, Lamia Sabry, et al.
Publicado: (2023)

Prognostic Significance of SOCS3 in Patients With Solid Tumors: A Meta-Analysis
por: Zheng, Xia, et al.
Publicado: (2022)

Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
por: Vargas, Alberto Olaya, et al.
Publicado: (2013)

Preoperative consolidation‐to‐tumor ratio is effective in the prediction of lymph node metastasis in patients with pulmonary ground‐glass component nodules
por: Chen, Yi‐Chung, et al.
Publicado: (2021)

Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma
por: Zhao, Liang, et al.
Publicado: (2022)

Tumor size is an independent risk predictor for metachronous colorectal cancer
por: Kato, Takaharu, et al.
Publicado: (2016)

The decay and consolidation of effector-independent motor memories
por: Bao, Shancheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p433hamch04tcr903481d7pvv3